Carl Sullivan - Author for 24/7 Wall St.
Lastest Stories by Carl Sullivan
The antitrust push against Facebook and other tech giants may be gaining steam but investors don’t seem too worried.
Published:
A tool that partners can embed in their apps could give Snap a new revenue stream and more upside for its stock.
Published:
Apple will reportedly switch to its own chips for Macs and will soon start producing 5G iPhones.
Published:
There may be a new dawn for Aurora Cannabis as online sales rise, new retail outlets open, and Reliva deal offers access to U.S. market.
Published:
Which retailer wouldn’t want to have a hit with Chinese consumers? Investors have an appetite for Beyond Meat as it makes fresh inroads into China, the world’s largest consumer market.
Published:
Analysts see some magic in Disney stock as resorts and theme parks reopen and NBA resumes play.
Published:
Analysts clear Boeing stock for takeoff as travel demand picks up.
Published:
AMD is optimistic about the future, particularly the data center business, even if analysts don’t see much upside for the stock.
Published:
Government backing of Fannie Mae and Freddie Mac looks crucial as the pandemic impacts mortgage delinquencies.
Published:
Facebook, under fire over President Trump’s posts, will label foreign state content. Do investors care?
Published:
Amarin is on hold as generic rivals seek to copy its potential blockbuster Vascepa.
Published:
Lyft stock jumped this week after the ride-sharing company revised its outlook as riders slowly return.
Published:
Nike doesn’t shy away from difficult subjects, and the current protest movement is no exception.
Published:
AT&T adapts its advertising to troubled times, spending more on live news and targeting stay-at-home consumers online.
Published:
Amarin is going ahead with a big marketing campaign for potential COVID treatment Vascepa after a disruption caused by the pandemic.
Published: